Literature DB >> 12692483

Cystic maculopathy with normal capillary permeability secondary to docetaxel.

Bruce A Teitelbaum1, David J Tresley.   

Abstract

BACKGROUND: Cystic maculopathy without leakage on fluorescein angiography has been described in cases of toxicity to niacin. We present a similar case of cystic maculopathy due to docetaxel (Taxotere) in the treatment of breast cancer. CASE REPORT: A 53-year-old Asian female presented with complaints of decreased vision soon after the initiation of treatment for breast cancer with docetaxel. A cystic maculopathy with a normal fluorescein angiogram was found on examination. Significant improvement in visual acuity along with resolution of the cystic maculopathy was found after changing to an alternate antineoplastic agent.
CONCLUSION: Docetaxel may be associated with cystic maculopathy that does not display angiographic evidence of abnormal capillary permeability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692483     DOI: 10.1097/00006324-200304000-00004

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  24 in total

1.  Detection of cystoid macular edema with three-dimensional optical coherence tomography versus fluorescein angiography.

Authors:  Yanling Ouyang; Pearse A Keane; Srinivas R Sadda; Alexander C Walsh
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-31       Impact factor: 4.799

2.  Electrophysiological evaluation of visual pathways in paclitaxel-treated patients.

Authors:  V Scaioli; A Caraceni; C Martini; S Curzi; G Capri; G Luca
Journal:  J Neurooncol       Date:  2005-08-25       Impact factor: 4.130

3.  Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease.

Authors:  Igor Kozak; Victoria L Morrison; Thomas M Clark; Dirk-Uwe Bartsch; Byung Ro Lee; Iryna Falkenstein; Ajay M Tammewar; Francesca Mojana; William R Freeman
Journal:  Retina       Date:  2008-04       Impact factor: 4.256

4.  Optical coherence tomography: clinical applications in medical practice.

Authors:  Abdullah Al-Mujaini; Upender K Wali; Sitara Azeem
Journal:  Oman Med J       Date:  2013-03

5.  Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.

Authors:  Nanami Nomi; Manami Ota; Miho Fukumura; Yoshihisa Nuno; Makoto Hatano; Makiko Wakuta; Ryoji Yanai; Kazuhiro Kimura
Journal:  Jpn J Ophthalmol       Date:  2017-12-21       Impact factor: 2.447

6.  Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report.

Authors:  Emma Bassi; Vera Loizzi; Claudio Furino; Rosa Martino; Giovanni Alessio; Cicinelli Ettore; Gennaro Cormio
Journal:  Mol Clin Oncol       Date:  2017-06-21

7.  The mystery of angiographically silent macular oedema due to taxanes.

Authors:  Tatiana I Kuznetcova; Petr Cech; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2012-04-08       Impact factor: 2.031

8.  A case of cystoid macular edema associated with Paclitaxel chemotherapy.

Authors:  Dong Sik Ham; Joo Eun Lee; Hyun Woong Kim; Il Han Yun
Journal:  Korean J Ophthalmol       Date:  2012-09-12

9.  Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema.

Authors:  Mark M Hassall; Nicholas Howard Andrew
Journal:  BMJ Case Rep       Date:  2016-04-19

Review 10.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.